INIS
spheroids
100%
evaluation
100%
gliomas
100%
radiations
100%
blood-brain barrier
71%
humans
57%
drugs
42%
growth
42%
in vitro
42%
glioblastomas
42%
interactions
28%
irradiation
28%
proteins
14%
mutations
14%
cell proliferation
14%
kinetics
14%
reduction
14%
tumors
14%
radiotherapy
14%
transport
14%
delivery
14%
volume
14%
brain
14%
fluorescence
14%
therapeutic agents
14%
additives
14%
fractionated irradiation
14%
Keyphrases
Temozolomide
100%
Binimetinib
100%
MEK162
100%
Preclinical Evaluation
100%
Glioblastoma multiforme
42%
ERK MAPK
28%
ERK Pathway
28%
Human Glioblastoma
28%
Aggressive Subtypes
14%
In Vitro Blood-brain Barrier Model
14%
Fractionated Irradiation
14%
Free Drug
14%
Cerebral Microcirculation
14%
Transwell System
14%
Human Brain Microvascular Endothelial Cells (HBMEC)
14%
Multicellular Spheroids
14%
Pharmacology, Toxicology and Pharmaceutical Science
Binimetinib
100%
Temozolomide
100%
Glioblastoma
44%